AstraZeneca secures Japanese approval for Tagrisso lung cancer treatment

… inoperable or recurrent non-small cell lung cancer (NSCLC) that is resistant to … EU approvals.
"As first-in-class lung cancer treatment directed at the T790M … proportion of Japanese patients with lung cancer have the EGFR mutation and …